---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011171"
form_type: "8-K"
ticker: "DYN"
cik: "0001818794"
company_name: "Dyne Therapeutics, Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:51:29.610593+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Dyne Therapeutics shareholders elect Hurwitz and Kersten to board, ratify auditor

## Summary
- Edward Hurwitz elected as Class II director: 20,392,039 for, 7,406,127 withheld, 3,170,612 broker non-votes.
- Dirk Kersten elected as Class II director: 20,066,236 for, 7,731,930 withheld, 3,170,612 broker non-votes.
- Ratified Deloitte & Touche as auditor for FY2022: 30,967,416 for, 362 against, 1,000 abstain.
- Annual meeting held June 3, 2022.

## SEC filing metadata
- accession: 0000950170-22-011171
- form_type: 8-K
- ticker: DYN
- cik: 0001818794
- company_name: Dyne Therapeutics, Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818794/000095017022011171/0000950170-22-011171-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818794/000095017022011171/dyn-20220603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011171
- JSON: https://secwatch.observer/filing/0000950170-22-011171.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011171.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.